Emergent Biosolutions is a global specialty biopharmaceutical company offering specialized products that address medical needs and emerging health threats. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. Emergent Biosolutions focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats. 

Employee Rating

3.1More
TypePublic
HQGaithersburg, US
Founded1998
Size (employees)1,256 (est)+15%
Websiteemergentbiosolutions.com
Emergent Biosolutions was founded in 1998 and is headquartered in Gaithersburg, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Emergent Biosolutions

Fuad El-Hibri

Fuad El-Hibri

Executive Chairman of the Board of Directors
Daniel J. Abdun-Nabi

Daniel J. Abdun-Nabi

CEO
Robert G. Kramer

Robert G. Kramer

President and Chief Operating Officer
Richard S. Lindahl

Richard S. Lindahl

Executive Vice President, Chief Financial Officer and Treasurer
Adam R. Havey

Adam R. Havey

Executive Vice President, Business Operations
Atul Saran

Atul Saran

Executive Vice President, Corporate Development and General Counsel
Show more

Emergent Biosolutions Office Locations

Emergent Biosolutions has offices in Gaithersburg, Winnipeg, Washington, Singapore and in 6 other locations
Gaithersburg, (HQ)
400 400 Professional Dr
Baltimore,
1111 S Paca St
Baltimore,
5901 E Lombard St
Hattiesburg,
46 Shelby Thames Dr
Lansing,
3500 N Martin Luther King Jr Blvd
Seattle,
1050 2401 4th Ave
Show all (11)
Report incorrect company information

Emergent Biosolutions Financials and Metrics

Emergent Biosolutions Revenue

Emergent Biosolutions's revenue was reported to be $560.87 m in FY, 2017
USD

Revenue (Q3, 2018)

173.7m

Net income (Q3, 2018)

20.9m

EBIT (Q3, 2018)

21.3m

Market capitalization (4-Dec-2018)

3.5b

Closing stock price (4-Dec-2018)

68.7

Cash (30-Sep-2018)

339.4m
Emergent Biosolutions's current market capitalization is $3.5 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

312.7m404.5m522.8m488.8m560.9m

Revenue growth, %

21%0%

Cost of goods sold

62.1m

Gross profit

250.6m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

89.1m53.9m110.3m138.0m63.6m126.1m164.9m111.0m101.5m142.9m116.9m100.8m149.4m117.8m220.2m173.7m

Cost of goods sold

20.1m

Gross profit

69.0m

Gross profit Margin, %

77%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

179.3m280.5m312.8m271.5m178.3m

Accounts Receivable

60.6m58.8m120.8m138.5m143.7m

Inventories

14.6m65.7m76.9m74.0m142.8m

Current Assets

273.1m432.2m538.6m510.2m485.4m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

30.3m36.7m62.9m51.8m82.6m

Depreciation and Amortization

19.0m42.6m

Inventories

518.0k4.2m(11.3m)(9.0m)6.1m

Accounts Payable

(551.0k)(9.3m)4.7m(14.8m)16.1m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

15.0m(20.2m)(15.2m)6.6m(21.5m)(7.4m)29.5m4.0m(7.0m)14.4m10.5m15.1m48.7m45.2m66.2m

Depreciation and Amortization

13.5m6.8m15.3m24.3m8.5m17.3m25.9m8.8m17.8m28.2m10.2m20.1m29.9m12.4m24.7m37.1m

Inventories

(1.2m)(4.0m)1.2m4.7m(16.5m)(19.0m)(14.4m)(11.3m)(19.7m)(16.2m)3.3m3.5m5.1m(12.4m)3.4m17.1m

Accounts Payable

(1.6m)(10.7m)(10.4m)(11.2m)1.1m2.1m1.9m385.0k11.3m(1.3m)81.0k4.2m3.0m3.6m(4.4m)(5.7m)
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics

Emergent Biosolutions Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Adapt PharmaAugust 29, 2018$735 m
PaxVaxAugust 10, 2018$270 m
Report incorrect company information

Emergent Biosolutions Online and Social Media Presence

Embed Graph
Report incorrect company information

Emergent Biosolutions Company Life and Culture

Report incorrect company information

Emergent Biosolutions Frequently Asked Questions

  • When was Emergent Biosolutions founded?

    Emergent Biosolutions was founded in 1998.

  • Who are Emergent Biosolutions key executives?

    Emergent Biosolutions's key executives are Fuad El-Hibri, Daniel J. Abdun-Nabi and Robert G. Kramer.

  • How many employees does Emergent Biosolutions have?

    Emergent Biosolutions has 1,256 employees.

  • What is Emergent Biosolutions revenue?

    Latest Emergent Biosolutions annual revenue is $560.9 m.

  • What is Emergent Biosolutions revenue per employee?

    Latest Emergent Biosolutions revenue per employee is $446.6 k.

  • Who are Emergent Biosolutions competitors?

    Competitors of Emergent Biosolutions include Adverse Health, Luitpold Pharmaceuticals and ContinuumRx.

  • Where is Emergent Biosolutions headquarters?

    Emergent Biosolutions headquarters is located at 400 400 Professional Dr, Gaithersburg.

  • Where are Emergent Biosolutions offices?

    Emergent Biosolutions has offices in Gaithersburg, Winnipeg, Washington, Singapore and in 6 other locations.

  • How many offices does Emergent Biosolutions have?

    Emergent Biosolutions has 11 offices.